Growth Metrics

Thermo Fisher Scientific (TMO) Cash from Investing Activities (2016 - 2025)

Thermo Fisher Scientific's Cash from Investing Activities history spans 17 years, with the latest figure at $891.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 4355.0% year-over-year to $891.0 million, compared with a TTM value of -$4.0 billion through Dec 2025, up 30.71%, and an annual FY2025 reading of -$4.0 billion, up 30.71% over the prior year.
  • Cash from Investing Activities for Q4 2025 was $891.0 million at Thermo Fisher Scientific, up from -$4.1 billion in the prior quarter.
  • The five-year high for Cash from Investing Activities was $891.0 million in Q4 2025, with the low at -$18.7 billion in Q4 2021.
  • Average Cash from Investing Activities over 5 years is -$2.0 billion, with a median of -$580.5 million recorded in 2021.
  • Year-over-year, Cash from Investing Activities plummeted 2885.94% in 2021 and then skyrocketed 4355.0% in 2025.
  • Tracing TMO's Cash from Investing Activities over 5 years: stood at -$18.7 billion in 2021, then skyrocketed by 97.19% to -$525.0 million in 2022, then increased by 28.38% to -$376.0 million in 2023, then skyrocketed by 105.32% to $20.0 million in 2024, then skyrocketed by 4355.0% to $891.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Cash from Investing Activities are $891.0 million (Q4 2025), -$4.1 billion (Q3 2025), and -$288.0 million (Q2 2025).